Redmile Group, LLC - 02 Jul 2025 SCHEDULE 13D/A Report for FATE THERAPEUTICS INC Common Stock, par value $0.001 per share (FATE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
FATE THERAPEUTICS INC Common Stock, par value $0.001 per share
Symbol
FATE
Shares outstanding
120,413,282 shares
Disclosed Ownership
17,941,579 shares
Ownership
15%
Form type
SCHEDULE 13D/A
Filing time
03 Jul 2025, 16:01:26 UTC
Date of event
02 Jul 2025
Previous filing
26 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 15% 17,941,579 0 17,941,579 /s/ Jeremy C. Green Managing Member 0001425738
Jeremy C. Green 15% 17,941,579 0 17,941,579 /s/ Jeremy C. Green Jeremy C. Green 0001650527
RedCo II Master Fund, L.P. 11% 13,479,013 0 13,479,013 /s/ Jeremy C. Green Managing Member of RedCo II (GP), LLC, its General Partner 0001921783